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We previously reported that among the 37 RING finger pro-
tein (RNF) family members, RNF183 mRNA is specifically ex-
pressed in the kidney under normal conditions. However, the
mechanism supporting its kidney-specific expression pattern
remains unclear. In this study, we elucidated the mechanism of
the transcriptional activation ofmurineRnf183 in inner-medul-
lary collecting duct cells. Experiments with anti-RNF183 anti-
body revealed that RNF183 is predominantly expressed in the
renal medulla. Among the 37 RNF family members, Rnf183
mRNA expression was specifically increased in hypertonic con-
ditions, a hallmark of the renal medulla. RNF183 up-regulation
was consistent with the activation of nuclear factor of activated
T cells 5 (NFAT5), a transcription factor essential for adaptation
to hypertonic conditions. Accordingly, siRNA-mediated knock-
down of NFAT5 down-regulated RNF183 expression. Further-
more, the 3,466 to 3,136-bp region upstream of the mouse
Rnf183 promoter containing the NFAT5-binding motif is con-
served among mammals. A luciferase-based reporter vector
containing theNFAT5-binding site was activated in response to
hypertonic stress, but was inhibited by a mutation at the
NFAT5-binding site. ChIP assays revealed that the binding of
NFAT5 to this DNA site is enhanced by hypertonic stress. Of
note, siRNA-mediated RNF183 knockdown increased hyperto-
nicity-induced caspase-3 activation and decreased viability of
mIMCD-3 cells. These results indicate that (i) RNF183 is predom-
inantly expressed in the normal renal medulla, (ii) NFAT5 stimu-
lates transcriptional activation of Rnf183 by binding to its cognate
binding motif in the Rnf183 promoter, and (iii) RNF183 protects
renal medullary cells from hypertonicity-induced apoptosis.
The renal medulla is the only tissue that is constantly under
hypertonic conditions to concentrate urine through water reab-
sorption in mammals (1). The driving forces for water reabsorp-
tion are elevated concentrations of sodium chloride and urea,
which create exceptionally hypertonic conditions (600 and 2,000
mosmol/kg H2O under conditions of diuresis and antidiuresis in
rodents, respectively) (2). Renal cells, particularly renal medullary
cells, partly adapt to the hypertonic conditions by accumulating
intracellular organic osmolytes that reduce intracellular ionic
strength. Nuclear factor of activated T cells 5 (NFAT5)3/tonicity-
responsive enhancer binding protein plays a key role in the adap-
tation tohypertonic conditionsbybinding to the consensusDNA-
binding element RNRNNTTTCCA (where N is any nucleotide,
and R is any purine) (3, 4). NFAT5 stimulates the transcription of
aldose reductase (AR/AKR1B1) (5, 6), sodium- and chloride-
dependent betaine transporter (BGT1/SLC6A13) (4, 6), sodium
myo-inositol co-transporter (SMIT/SLC5A3) (3, 6), and heat
shock protein 70 (HSP70/HSPA1B) (7, 8), which mediate the
intracellular accumulation of sorbitol, betaine, and myo-inositol
and functionas an intracellularmolecular chaperone, respectively.
In addition to these genes,many downstreamgenes ofNFAT5 are
known (9–15). However, a ubiquitin ligase that is directly acti-
vated by NFAT5 has not yet been reported.
Ubiquitin ligases are involved in a wide variety of cellular
events throughubiquitination (16, 17). RING finger protein 183
(RNF183) is a member of the RNF family, which functions as a
ubiquitin ligase (18). Previous studies have demonstrated that
RNF183mRNAexpression in the colon of patients with inflam-
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matory bowel disease (IBD) and colorectal cancers was 5-
and 2-fold higher than that in control subjects; in these
patients, RNF183 promotes intestinal inflammation (19) and
proliferation and metastasis of cancers (20), respectively. On
the contrary, we previously demonstrated that RNF183 was
specifically expressed in human and mouse kidney, and that
mouse Rnf183 mRNA expression in the kidney was 324-
fold higher than in the colon (21). To date, however, the
reason why Rnf183 mRNA is selectively expressed in the
kidney remains unclear.
In this study, we demonstrated that RNF183 is dominantly
expressed in the renal medulla and that NFAT5 regulates
Rnf183 transcription in mouse inner-medullary collecting duct
(mIMCD-3) cells.
Results
RNF183 is predominantly expressed in the renal medulla
RNF183 has been described as a ubiquitin ligase, which is
expressed in normal colonic epithelial cells and colorectal can-
cer cells (19, 20). In addition, we previously reported that
Rnf183 mRNA expression in the kidney is 324-fold higher
than in the colon (21); however, RNF183 protein expression in
the kidney remains unclear. To detect RNF183 protein expres-
sion, we generated an affinity-purified antibody using recombi-
nant deletion mutant RNF183 (amino acids 61–158) lacking a
RING finger domain at its N terminus and a transmembrane
domain at its C terminus (Fig. 1A). The antibody specifically
recognized GFP-tagged RNF183 at 50 kDa, which was tran-
siently transfected into human embryonic kidney 293 (HEK293)
cells (Fig. 1B). Immunofluorescence staining using HeLa cells
transiently transfected with GFP-RNF183 showed that punc-
tate signals of GFP-RNF183 were recognized by the anti-
RNF183 antibody (Fig. 1C). GFP signals were localized in the
late endosome/lysosome (Lamp1) and early endosome (EEA1),
with additional weak signal in the recycling endosome (trans-
ferrin receptor) and Golgi complex (GM130) but not in the
endoplasmic reticulum (calnexin) or mitochondria (COX IV)
(Fig. 1D and Fig. S1). To evaluate endogenous RNF183 protein
expression, we performed RT-PCR and Western blot analy-
sis using tissue extracts in 4-week-old mice. Western blot-
ting revealed that endogenous RNF183 protein was expressed
markedly in the kidney, particularly in the renal medulla, and
in the thymus (Fig. 1, F and H), consistent with Rnf183
mRNA expression (Fig. 1, E and G). Megalin and AKR1B1
were used as positive controls for the renal cortex and
medulla, respectively.
Figure 1. RNF183 is predominantly expressed in the renal medulla. A, schematic representation of the predicted domain organization of mouse
RNF183 (middle), deletion mutant RNF183 (amino acids 61–158) (top), and GFP-RNF183 (bottom) used in this study. Anti-RNF183 antibody was gener-
ated using deletion mutant RNF183. The number on the right indicates the peptide length. B, Western blotting of HEK293 cells transfected with
GFP-RNF183. The anti-RNF183 and GFP antibody recognized a GFP-RNF183 at 50 kDa. C, confocal images of immunofluorescence with anti-RNF183
antibody (top, red) and GFP signals (middle, green) in HeLa cells transfected with GFP-RNF183. Bar, 10 m. D, confocal images of immunofluorescence
with GFP signals (middle panels, green) and various antibodies for organelle markers (EEA1 and Lamp1; top panels, red) in HeLa cells transfected with
GFP-RNF183. Bars, 10 m. E, RT-PCR analysis of Rnf183mRNA in 10 tissues frommice. F, tissue immunoblot analysis of RNF183. Tissue lysates containing
equal amounts of total protein were analyzed by Western blotting. G and H, expression patterns of RNF183 mRNA and protein in the renal cortex and
medulla. Mouse tissue lysates were analyzed by RT-PCR (G) and Western blotting (H). Liver was used as a negative control. Megalin and AKR1B1 were
used as positive controls for the renal cortex andmedulla, respectively. Arrowhead, full-lengthmegalin (H,middle). The results shown are representative
of at least three replicates in independent observations.
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RNF183 expression is up-regulated in response to hypertonic
stress
Renal medullary cells are constantly exposed to extreme
hypertonic stress to concentrate the urine (1). Therefore, using
quantitative real-time RT-PCR (qRT-PCR), we examined
whether RNF183 expression and the other transmembrane
RNF family members, those containing RING finger (C3H2C3
or C3HC4) and transmembrane domains, are up-regulated in
response to hypertonic stress. Mouse IMCD-3 cells were incu-
batedwith isotonicmediumorNaCl- or sucrose-supplemented
medium. The extracellular tonicity was increased by 150
mosmol/kg H2O (final osmolality: 450 mosmol/kg H2O) by
adding 75 mM NaCl or 150 mM sucrose. Akr1b1 (5, 6) and
Hapa1b (7, 8) were used as positive controls for tonicity depen-
dence. We found that Rnf183mRNA expression was markedly
up-regulated in a tonicity-dependent manner in both hyper-
tonic NaCl- and sucrose-treated cells compared with that in
isotonic control cells (Fig. 2A), which was consistent with the
Akr1b1 and Hapa1b up-regulation patterns (Fig. 2A). Rnf128
and Rnf19B were modestly up-regulated in a tonicity-depen-
dent manner. Further, Rnf24, Rnf13, Rnf167, Rnf43, Syvn1,
Amfr, Rnf145, Rnf5, Rnf185, and Rnf170 were slightly up-regu-
lated in cells treated with only 75 mM NaCl; the other RNF
family members were not up-regulated (Fig. 2A). Western blot
analysis showed that RNF183 and AKR1B1 protein expression
was up-regulated in a tonicity-dependent manner (Fig. 2, B–E).
However, Rnf183 mRNA was not up-regulated under hypoxic
conditions (oxygen concentration, 1 and 0.3%) (Fig. S2), which
is another characteristic of the renal medulla. These results
suggest that hypertonic conditions play a more important role
Figure 2. RNF183 is up-regulated in response to hypertonic stress. A, the hypertonic response of Rnf183 (top) and the other transmembrane RNF family
member (middle, 18 of the C3H2C3 type; bottom, 17 of the C3HC4 type) mRNA levels in mIMCD-3 cells. Akr1b1 and Hspa1bwere used as tonicity-dependent
positive controls (top). Cellswere treatedwith isotonicor the indicatedNaCl- or sucrose-supplementedmedium for 12handanalyzedbyqRT-PCR (n5).Band
D, the tonicity-dependent inductionof RNF183 andAKR1B1protein inmIMCD-3 cells. Cellswere culturedunder hypertonic conditions by adding the indicated
NaCl (B) or sucrose (D) supplementation for 12 h and analyzed by Western blotting. C and E, quantitative analysis of RNF183 (left) and AKR1B1 (right) protein
expression in NaCl (B) and sucrose (D) (n 5). F, the up-regulation patterns of RNF183 and AKR1B1 proteins in four renal cell lines in response to hypertonic
stress. NRK-52E, NRK-49F, mIMCD-3, and HEK293 cells were treated with isotonic or 75 mM NaCl–supplemented medium for 12 h and analyzed by Western
blotting.HEK293 cells transfectedwithmouseRNF183wereusedas apositive control. Datawere analyzedbyone-wayANOVA, followedbypost hoc tests using
t tests with Bonferroni correction. Values represent mean S.D. (error bars). *, p 0.05; **, p 0.01; ***, p 0.001 (versus isotonic control).
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in RNF183 expression than hypoxic conditions.Next, we exam-
ined whether RNF183 up-regulation was different between
mIMCD-3 cells and other renal cell lines. Normal rat kidney
(NRK)-52E (a rat kidney tubular epithelial cell line), NRK-49F
(a rat kidney interstitial fibroblast cell line), mIMCD-3, and
HEK293 cells were used. HEK293 cells transiently transfected
with mouse RNF183 were used as a positive control. We found
that RNF183 expression increased markedly in mIMCD-3 cells
treated with hypertonic NaCl and increased slightly in NRK-
52E cells, whereas no expression was detected in NRK-49F and
HEK293 cells (Fig. 2F). Interestingly, the difference in RNF183
expression among renal cell lines was similar to that inAKR1B1
expression. The similarity between RNF183 and AKR1B1 up-
regulation in response to hypertonic stress suggests that
NFAT5 regulates RNF183 expression as well as AKR1B1
expression.
RNF183 expression is up-regulated concurrently with NFAT5
activation
The NFAT5 transcription factor is the master regulator for
hypertonic stress in mammals (22). In response to hypertonic
stress, NFAT5 activation is achieved by a combination of
NFAT5 induction and localization into the nucleus (4, 23, 24).
Thus, we evaluated the effects of hypertonicity on NFAT5 acti-
vation in mIMCD-3 cells. We performed immunofluorescence
staining of NFAT5 and plotted the fluorescence intensity
along a line drawn through the nucleus. These analyses
showed that NFAT5 was present in both the cytoplasm and
nucleus under isotonic conditions (Fig. 3A). Hypertonic
stimulation for 3 h reduced NFAT5 cytoplasmic expression
and slightly enhanced nuclear expression, and stimulation
for 12 h drastically enhanced nuclear expression (Fig. 3A).
Western blot analysis demonstrated that the total abun-
dance of NFAT5 protein significantly increased after 3 h of
hypertonic stimulation and peaked at 9 h (Fig. 3, B and C),
consistent with NFAT5 localization (Fig. 3A). Moreover,
qRT-PCR analysis revealed that the expression of Rnf183
and NFAT5 downstream genes, Akr1b1 (5, 6) andHspa1b (7,
8), concurrently increased after 3 h of hypertonic stimula-
tion (Fig. 3D). The RNF183 and AKR1B1 protein levels sig-
nificantly increased after 6 and 9 h of hypertonic stimulation
(Fig. 3, E and F), respectively. In contrast to the downstream
genes of NFAT5, the Tnfa mRNA level, which is that of
NF-B, peaked after 3 h of hypertonic stimulation and
decreased after 6 h (Fig. S3). These results demonstrated that
RNF183 expression was up-regulated under hypertonic condi-
tions and was accompanied byNFAT5 activation and the up-reg-
Figure 3. RNF183 is up-regulated concurrently with NFAT5 activation. A, nuclear translocation of NFAT5 in response to hypertonic stress. Mouse IMCD-3
cells were treated with hypertonic medium (75 mM NaCl– or 150 mM sucrose–supplemented medium) for the indicated time and subjected to immunofluo-
rescence staining with anti-NFAT5 antibody (top panels, green). Bars, 20 m. The NFAT5 fluorescence intensities of cells were plotted on line graphs (bottom
panels). Gray lines correspond to the relative fluorescence of cells marked with gray arrows. B, increase in total NFAT5 protein abundance in response to
hypertonic stress. Mouse IMCD-3 cells were treated with 75 mM NaCl–supplemented medium for the indicated time and analyzed by Western blotting. C,
quantification of data from B (n 4).D and E, time-course analysis ofmRNAandprotein in response to hypertonic stress.Mouse IMCD-3 cellswere treatedwith
NaCl-supplementedmedium for the indicated time and analyzed by qRT-PCR (D; n 6) or byWestern blotting (E). F, quantitative analysis of RNF183 (left) and
AKR1B1 (right) expression in E (n  5). Data were analyzed by one-way ANOVA, followed by post hoc tests using t tests with Bonferroni correction. Values
represent mean S.D. (error bars). *, p 0.05; **, p 0.01; ***, p 0.001 (versus isotonic control).
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ulation of NFAT5 downstream genes, suggesting that RNF183
expression is directly mediated by NFAT5.
NFAT5 knockdown and p38/MAPK inhibitor SB203580
attenuate hypertonicity-induced RNF183 expression
To determine the effect of NFAT5 inhibition on RNF183
expression, mIMCD-3 cells were transfected with siRNA oligo-
nucleotides targeting NFAT5 (NFAT5 siRNA 1) or negative
control siRNA (NC siRNA). After 12 h of hypertonic stimula-
tion, the NFAT5 protein levels were significantly reduced in
mIMCD-3 cells transfected with NFAT5 siRNA 1 (Fig. 4,A and
B). NFAT5 knockdown significantly inhibited the hypertoni-
city-induced RNF183 protein and mRNA expression of both
Rnf183 and Akr1b1 (Fig. 4, C–E). Another NFAT5 siRNA
(NFAT5 siRNA 2) produced similar results (Fig. S4, A–C). The
hypertonic stress signal ismediated through p38/MAPK,which
regulates NFAT5 activation in mammals (12, 13, 25, 26). Thus,
to determine the effect of p38/MAPK inhibition on RNF183
expression, mIMCD-3 cells were treated with 75 mM NaCl–
supplemented medium in the presence of the indicated
concentration of SB203580. The hypertonicity-induced pro-
tein and mRNA expression of RNF183 and NFAT5 down-
stream genes Akr1b1 and Sgk1 were concurrently inhibited
by SB203580 in a dose-dependent manner (Fig. 4, F and G).
These results demonstrated that RNF183 expression de-
pends on NFAT5.
Identification of the Rnf183 enhancer region that responds to
hypertonic stress
To identify the putative enhancer region in the Rnf183 pro-
moter, we searched for an evolutionarily conserved region
(ECR) within 5,000 bp upstream of the human RNF183 gene
using the ECR browser (27). The 319-bp region (4,367 to
4,049-bp region; numbers indicate nucleotide positions re-
lative to the transcription start site) upstream of the human
RNF183 gene was identified as conserved in mammals (blue;
Fig. 5A). Although its actual position from the transcription
start site varies among the species (Fig. 5B), it shows high
sequence identity with the corresponding region in the follow-
ing mammals: Mus musculus, 71%; Rattus norvegicus, 73%;
Canis familiaris, 81%; Bos taurus, 80%;Macaca mulatta, 94%;
and Pan troglodytes, 98%.We next searched for potential bind-
ing sites for various transcription factors within the mamma-
lian conserved region of RNF183 genes (3,466 to 3,136,
mouse (Table S1);1,978 to1,664, rat (top right);4,367 to
4,049, human (bottom right)) using the JASPARdatabase (28).
This analysis identified one binding site for NFAT proteins
conserved among mouse, rat, and human (Table 1 and Table
S1). The sequences (GTACTTTTCCA (3,342 to 3,332;
numbers indicate the nucleotide position relative to the tran-
scription start site of mouse Rnf183), GTACTTTTCCA
(1,870 to 1,860; numbers indicate the nucleotide position
Figure 4. NFAT5 knockdown and p38/MAPK inhibitor SB203580 attenuate hypertonicity-induced RNF183 expression. A, inhibition of NFAT5 expres-
sionusing siRNA.Mouse IMCD-3 cells transfectedwithNFAT5 siRNA1orNC siRNAwere treatedwith isotonic or 75mMNaCl–or 150mMsucrose–supplemented
medium for 12 h and analyzed by Western blotting. B, quantification of data from A (n  4). C, effect of NFAT5 knockdown on RNF183 protein expression
induced by hypertonicity.D, quantitative analysis of RNF183 in C (n 4). E, effect of NFAT5 knockdown on Rnf183 (left) and Akr1b1 (right) mRNA (n 5). F and
G, effect of p38/MAPK inhibitor SB203580 onmRNAexpression of Rnf183,Akr1b1, and Sgk1 (F) and protein expression of RNF183 (G). Cells were treatedwith 75
mM NaCl for 12 h in the presence of the indicated concentrations of SB203580 (1 h of preincubation) and analyzed by qRT-PCR (F) (n 6) or Western blotting
(G). Datawere analyzedbyone-wayANOVA, followedbypost hoc tests using t testswith Bonferroni correction. Values representmean S.D. (error bars). *,p
0.05; **, p 0.01; ***, p 0.001 (versus NC).
NFAT5 regulates Rnf183 transcription
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Figure 5. Identification of the Rnf183 enhancer region that responds to hypertonic stress. A, screen capture from the ECR Browser website
(http://ecrbrowser.dcode.org/) (57) (please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other
third party hosted site) of the human RNF183 gene with ECR in the genomes of mouse, rat, canis, cattle, rhesus, and chimpanzee. The peaks in red show
comparative pairwise ECR between human and the indicated mammals. The 319-bp region (4,367 to 4,049 region; numbers indicate nucleotide
positions relative to the transcription start site) is conserved in mammals (blue). B, location and sequence of the conserved NFAT5 DNA–binding site
(yellow backgroundwith underline; mouse,3,342 to3,332 bp; rat,1,870 to1,860 bp; human,4,256 to4,246 bp). Conserved bases around the
binding site are indicated as blue background. NFAT5 consensus sequence (RNRNNTTTCCA) is indicated below the site. C, scheme of the mouse Rnf183
promoter region and reporter constructs. Two NFAT5 DNA–binding sites are indicated in 3.5 kbp upstream of the mouse Rnf183 start site. 3.5 kbp-Luc
and 2.0 kbp-Luc constructs consist of3.5 kbp and 2.0 kbp upstream of the mouse Rnf183 transcription start site, respectively. D, effect of hypertonic
stress on luciferase activities. Mouse IMCD-3 cells transfected with 3.5 kbp-Luc or 2.0 kbp-Luc constructs were treated with isotonic or 75 mM NaCl–
supplemented medium for 24 h. The pGL4-Luc without the promoter was used as a control. Firefly luciferase activities were normalized to Renilla
luciferase signals (n 3). Data were analyzed by one-way ANOVA, followed by post hoc tests using t tests with Bonferroni correction. Values represent
mean  S.D. (error bars). **, p  0.01; N.S., p  0.05.
Table 1
Conserved putative transcription factor binding sites in the RNF183 enhancer region
Transcription factor–binding sites predicted using the JASPAR software are shown in the mammalian conserved region of RNF183 genes (mouse,3,466 to3,136; rat,
1,978 to 1,664; human, 4,367 to 4,049). Conserved binding sites from mice, rats, and humans were selected from the potential binding sites with a 95% chance
(relative score) of binding to any of the listed transcription factors (Table S1). The conserved NFAT5 DNA–binding site is indicated in boldface type. NFIC, nuclear factor
1 C-type; ZNF354C, zinc finger protein 354C; NFE2L1-MafG, nuclear factor erythroid 2–related factor 1 and V-maf avian musculoaponeurotic fibrosarcoma oncogene
homolog G complex; NFAT, nuclear factor of activated T cells; Atoh1, atonal homolog1; Prrx2, paired-related homeobox 2.
Species
Transcription
factor
JASPAR
score
Relative
score Start End Strand
Predicted site
sequence
%
M. musculus NFIC 8.520 96.1 3407 3402 1 TTGGCT
ZNF354C 8.723 99.2 3398 3393 1 CTCCAC
NFE2L1–MafG 8.072 96.8 3385 3380 1 TATGAC
NFAT 11.360 100.0 3338 3332 1 TTTTCCA
Atoh1 13.740 99.6 3333 3326 1 CAGCTGGC
Prrx2 9.124 100.0 3299 3295 1 AATTA
R. norvegicus NFIC 8.520 96.1 1935 1930 1 TTGGCT
ZNF354C 8.723 99.2 1926 1921 1 CTCCAC
NFE2L1–MafG 8.812 100.0 1913 1908 1 CATGAC
NFAT 11.360 100.0 1866 1860 1 TTTTCCA
Atoh1 13.740 99.6 1861 1854 1 CAGCTGGC
Prrx2 9.124 100.0 1826 1822 1 AATTA
Homo sapiens NFIC 8.520 96.1 4322 4317 1 TTGGCT
ZNF354C 8.723 99.2 4313 4308 1 CTCCAC
NFE2L1–MafG 8.812 100.0 4300 4295 1 CATGAC
NFAT 11.360 100.0 4252 4246 1 TTTTCCA
Atoh1 14.033 100.0 4247 4240 1 CAGATGGC
Prrx2 9.124 100.0 4208 4204 1 AATTA
NFAT5 regulates Rnf183 transcription
106 J. Biol. Chem. (2019) 294(1) 101–115
 at W
ashington U
niversity on N
ovem
ber 25, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
relative to the transcription start site of rat RNF183), and
GTGCTTTTCCA (4,256 to 4,246; numbers indicate the
nucleotide position relative to the transcription start site of
human RNF183)) were completely homologous with the
NFAT5 consensus sequence (RNRNNTTTCCA) (3, 4) (Fig.
5B). Furthermore, the sequences around the binding site were
highly conserved among mouse, rat, and human (blue back-
ground). Between the conserved region and the transcription
start site of the mouse Rnf183 gene (3,135 to 1), we found
another site (AGGTTTTTCCA;538 to528) that was com-
pletely homologous with the NFAT5 consensus sequence, but
not conserved among the species. To determine whether
NFAT5 acts on the Rnf183 promoter containing these sites to
activateRnf183 transcription, we performed luciferase reporter
assays using the promoter region in mIMCD-3 cells. A 3.5-kbp
(containing both NFAT5DNA–binding sites) or 2.0-kbp (con-
taining the nonconserved NFAT5 DNA–binding site) pro-
moter region of the mouse Rnf183 gene (pGL4–3.5 kbp-Luc
and pGL4–2.0 kbp-Luc, respectively; Fig. 5C) was used. The
reporter activity of pGL4–3.5 kbp-Luc, but not that of pGL4–
2.0 kbp-Luc or pGL4-Luc, was considerably induced by hyper-
tonic stress (Fig. 5D). These results demonstrated that the puta-
tive Rnf183 enhancer region has responsiveness to hypertonic
conditions.
Rnf183 enhancer region depends on NFAT5
To determine whether the putative Rnf183 enhancer region
depended on NFAT5, we examined the effects of NFAT5
knockdown, p38/MAPK inhibition, and the dominant negative
(DN) form of NFAT5 on luciferase activities. NFAT5 knock-
downmarkedly reduced the reporter activity of pGL4–3.5 kbp-
Luc (Fig. 6A and Fig. S4D), whereas FLAG-NFAT5 overexpres-
sion fully rescued the down-regulated reporter activity (Fig. 6B
and Fig. S5). p38/MAPK inhibitor SB203580 significantly
inhibited the hypertonicity-inducedRnf183 luciferase activities
(Fig. 6C), which is consistent with mRNA and protein expres-
sion of RNF183 (Fig. 4, F and G). Moreover, Rnf183 luciferase
activities were inhibited by overexpression of DN-NFAT5,
whereas they were up-regulated by that of the full-length
NFAT5 (Fig. 6D). These results suggest that the putativeRnf183
enhancer region depends on NFAT5.
Rnf183 is a direct target of NFAT5
We next performed luciferase reporter assays using pGL4–
3.5 kbp-Luc of WT and mutant having a mutation in the con-
served NFAT5 DNA–binding site (Fig. 7A). In mIMCD-3 cells
transfected with the mutant, reporter activities were markedly
reduced even in hypertonic conditions (Fig. 7B). Consistent
with this, NFAT5 overexpression markedly induced reporter
activity of WT, which was inhibited by the mutation (Fig. 7C).
To confirm whether NFAT5 directly binds to the conserved
binding site in the Rnf183 promoter, we performedChIP assays
using mIMCD-3 cells under hypertonic conditions (Fig. 7D)
and detected a high level of NFAT5 binding to the conserved
binding site in the endogenous Rnf183 promoter (Fig. 7, E and
F). These results indicated that NFAT5 directly acts on the
conserved NFAT5 DNA–binding site within the Rnf183 pro-
moter and facilitates its transcription in mIMCD-3 cells.
RNF183 expression provides protection against hypertonicity-
induced apoptosis
Stress induced by an elevated NaCl concentration mediates
apoptosis inmIMCD3 cells when osmolality is acutely raised to
600 mosmol/kg (29–31). Moreover, several NFAT5 down-
stream genes show a protective effect against hypertonicity-
induced apoptosis (9, 32, 33). Thus, to determine whether
RNF183 expression affects the osmotic tolerance of mIMCD-3
cells to high NaCl levels, mIMCD-3 cells were transfected with
siRNA oligonucleotides targeting RNF183 (RNF183 siRNA) or
NC siRNA. RNF183 siRNA effectively reduced the Rnf183
mRNA levels compared with NC siRNA (Fig. 8A). After 4 h of
exposure to 200 mM NaCl–supplemented medium, cleaved
caspase-3 protein levels and cleaved caspase-3–positive cells
(which are indexes of apoptosis) significantly increased in
mIMCD-3 cells transfected with RNF183 siRNA (Fig. 8, B and
C). Crystal violet assays revealed that RNF183 knockdown sig-
nificantly reduces cell viability under hypertonic conditions
(Fig. 8D). In contrast, RNF183 knockdown did not promote
caspase activation upon treatment of mIMCD-3 cells with the
apoptosis inducer staurosporine (Fig. S6). These results dem-
Figure 6. Rnf183 enhancer region depends on NFAT5. A, effect of NFAT5
knockdown on hypertonicity-induced luciferase activities. Cells cotrans-
fectedwith 3.5 kbp-Luc and siRNA (NFAT5 1 or NC)were treatedwith isotonic
or 75mMNaCl–or sucrose–supplementedmedium for 24h (n3).B, effect of
rescue with FLAG-NFAT5 on luciferase activities. Cells pretransfected with
siRNA (NFAT5 3 or NC) were cotransfectedwith 3.5 kbp-Luc and either empty
or pFLAG-NFAT5 vectors after 12 h of knockdown. After 24 h of cotransfec-
tion, cells were treated with isotonic or 75 mM NaCl–supplemented medium
for an additional 24 h (n  4). C, effect of p38/MAPK inhibitor SB203580 on
Rnf183 luciferase activities. Cells transfected with 3.5 kbp-Luc were treated
with 75 mM NaCl for 24 h in the presence of the indicated concentrations of
SB203580 (1 h of preincubation) (n  3). D, effect of overexpression with
FLAG-DN-NFAT5 and FLAG-NFAT5on luciferase activities. Cells cotransfected
with 3.5 kbp-Luc and either empty, pFLAG-DN-NFAT5, or pFLAG-NFAT5 vec-
tors were analyzed after 48 h of transfection (n 4). Data were analyzed by
one-way ANOVA, followed by post hoc tests using t tests with Bonferroni
correction. Values represent mean S.D. (error bars). *, p 0.05; **, p 0.01;
***, p 0.001.
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onstrate that RNF183 protects inner-medullary cells from
hypertonicity-induced apoptosis.
Rescue of RNF183 knockdown attenuates hypertonicity-
induced apoptosis
To eliminate the possibility of siRNA off-target effects,
mIMCD-3 cells transfected with RNF183 siRNA or NC siRNA
were rescued with siRNA-resistant 3	FLAG-RNF183, which
was expressed in mIMCD-3 cells under RNF183 knockdown
(Fig. 9A). After 4 h of exposure to 200mMNaCl–supplemented
medium, cleaved caspase-3 protein levels significantly de-
creased inmIMCD-3 cells rescuedwith 3	FLAG-RNF183 (Fig.
9B). Crystal violet assays showed that the rescue of RNF183
knockdown significantly improved cell viability under hyper-
tonic conditions (Fig. 9C). These results confirm that RNF183
protects inner-medullary cells from hypertonicity-induced
apoptosis.
Discussion
We identified the conserved NFAT5 DNA–binding site
in the Rnf183 enhancer region and found that this site in-
duced RFN183 reporter activity under hypertonic conditions,
whereas mutation at the site resulted in almost complete inhi-
bition of Rnf183 reporter activity. In addition, ChIP assays
revealed a high level of NFAT5 binding to the site. Thus, these
results demonstrated a mechanism of RNF183 up-regulation
under hypertonic conditions by which NFAT5 directly binds
to the conserved NFAT5 DNA–binding site in the Rnf183
enhancer region and leads to its transcriptional activation. This
is the first study to demonstrate that ubiquitin ligase can be
directly regulated by NFAT5. However, Yu et al. (19) demon-
strated thatmicroRNA-7 (miR-7) directly bound to the 3-UTR
of RNF183 mRNA, leading to RNF183 degradation and trans-
lational inhibition, and that down-regulation of miR-7 induced
RNF183 elevation in inflamed colon tissues of IBD patients and
colitic mice. Of the two regulators of RNF183 expression, we
considered NFAT5 to be more important than miR-7 in a nor-
mal kidney because the tissue distribution pattern of RNF183 is
different from that of miR-7 (34). The expression of miR-7 is
restricted to specific tissues of the brain, colon, and thymus,
whereas it is extremely low in the kidney, heart, liver, lung,
spleen, and stomach (34), which is not consistent with our
results on RNF183 expression (Fig. 1, E and F). Whereas
NFAT5 is broadly expressed as an essential factor during expo-
sure to the hypertonic environment (4), systemic or immature
thymocyte-specific NFAT5 knockout mice display profound
defects in the renal medulla and reduced thymocyte compart-
ment in the thymus, respectively (6, 35, 36). This is because
NFAT5 is activated by hypertonicity-dependent and -indepen-
dent pathways in the renal medulla (6, 37, 38) and thymus
(36), respectively. Consistent with these findings, RNF183 was
highly expressed in the renal medulla and was also expressed in
the thymus (Fig. 1, E–H). Therefore, we hypothesized a mech-
anism by which high RNF183 expression in the normal kidney
and thymus is predominantly regulated by the NFAT5 activa-
tion, but not miR-7.
We observed an 2–3-fold increase in the induction of
Rnf183 reporter activity following hypertonic stimulation. One
possible explanation for this mild induction of the Rnf183 pro-
moter is that only a short sequence of the Rnf183 promoter was
investigated. Consistent with our results, Hasler et al. (39) and
Chen et al. (12) have demonstrated that the activity of theAQP2
and SGK1 promoters (each containing one NFAT5-binding
element) increased 1.5- and 5-fold, respectively, following
hypertonic stimulation. However, at least five NFAT5-binding
Figure 7. Rnf183 is a direct target of NFAT5. A, location and site-directedmutagenesis of the conserved NFAT5 DNA–binding site. The sequences from the
pGL4–3.5 kbp-Luc of the WT and mutant are shown. Mutagenized bases are indicated by lowercase letters. B, effect of conserved site mutation on luciferase
activities. Cells transfected with WT or mutant were cultured in isotonic or 75 mM NaCl–supplemented medium for 24 h. The pGL4-Luc was used as a control.
Firefly luciferase activities were normalized to Renilla luciferase signals (n 4). C, effect of NFAT5 overexpression on luciferase activities. Cells transfectedwith
WT, mutant, empty, or pFLAG-NFAT5 were cultured in an isotonic medium for 36 h (n  5). D, schematic representation of the Rnf183 promoter and the
annealing sites of the primer set used in the ChIP assays. E, ChIP assay analysis of theNFAT5 binding to the Rnf183promoter inmIMCD-3 cells. ChIP assayswere
performed with the indicated antibodies. Immunoprecipitated (IP) DNA and input DNA were subjected to RT-PCR. IgG was used as a control. F, quantitative
analysis of RT-PCR in E. Results were normalized to input DNA (n 3). Data were analyzed by one-way ANOVA, followed by post hoc tests using t tests with
Bonferroni correction. Values represent mean S.D. (error bars). *, p 0.05; **, p 0.01; ***, p 0.001 (versus isotonic control).
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elements spread over 50-kb pairs, which participate in NFAT5-
mediated transcriptional stimulation, were revealed in the
SMIT promoter (3). Similarly, threeNFAT5-binding sequences
that were identified in the AKR1B1 promoter may collectively
participate in the hyperosmotic response (5). Therefore, other
NFAT5-binding elements may be present in regions of the
Rnf183 promoter that are further upstream or downstream.
Moreover, we demonstrated that Rnf183 reporter activity and
Rnf183 and Akr1b1 mRNA expression were concurrently re-
duced by NFAT5 knockdown under isotonic conditions. Sev-
eral previous studies have shown that, to some extent, NFAT5
knockdown or dominant negative NFAT5 expression inhibited
mRNA expression or promotor activity of its downstream
genes under isotonic conditions (7, 9, 39, 40). In contrast, two
studies have shown that NFAT5 inhibition did not affect the
basal expression of its downstream genes under isotonic condi-
tions (12, 41). This difference in NFAT5 inhibition may result
from variation in the basal NFAT5 protein levels because basal
AKR1B1 protein expression levels were high inmIMCD-3 cells
compared with those in other renal cell lines (Fig. 2F).
We further examined whether RNF183 was up-regulated by
hypoxia inmIMCD-3 cells because the renal medulla is charac-
teristically hypoxic (42). Although vascular endothelial growth
factor A (Vegfa) mRNA, which is downstream of the hypoxic
master regulator hypoxia-inducible factor 1 (HIF-1) (43), was
significantly up-regulated under hypoxia (oxygen concentra-
tion, 1 and 0.3%), Rnf183was not up-regulated (Fig. S2). More-
over, the HIF-1 DNA–binding site (ACGTG) was not observed
in the Rnf183 enhancer region (Table S1). These results suggest
that the high RNF183 expression in the renal medulla does not
result from hypoxia.
Our results demonstrated that Rnf183mRNA was markedly
up-regulated compared with the other transmembrane RNF
family members under hypertonic conditions and that the
siRNA-induced knockdown of RNF183 exacerbates apoptosis
and reduces cell viability in mIMCD-3 cells at 700 mosmol/
kg. Although the effects of RNF183 on adaptation to hyperto-
nicity appear to be mild, we consider RNF183 to be as im-
portant as other NFAT5-regulated genes. Lee et al. (44) dem-
onstrated up to a 1.5-fold increase in the hypertonicity-induced
LDH release in MEF cells transfected with siRNA targeting
SMIT, BGT1, AKR1B1, HSPA1B, etc. Shim et al. (33) have also
demonstrated an 20–30% decrease in cell viability following
100 mM NaCl supplementation in HSPA1B-knockout MEF
Figure 8. RNF183 expression provides protection against hypertonicity-induced apoptosis. A, inhibition of Rnf183 expression using siRNA. Mouse
IMCD-3 cells transfectedwith RNF183 siRNAorNC siRNAwere analyzed using qRT-PCR (n 3). B andC, effect of RNF183 knockdownonhypertonicity-induced
apoptosis. Cells transfected with the indicated siRNAs were treated with isotonic or 200mMNaCl–supplementedmedium for 4 h and analyzed usingWestern
blotting (B) or immunofluorescence staining (C) usinganti-cleavedcaspase-3–specific antibody.B, the accompanyingbargraph summarizes thequantification
of relative amounts of cleaved caspase-3 (n 3). C, the cleaved caspase-3 fluorescence–positive cells (red) are marked with white arrows. Bars, 100 m. The
number of cleaved caspase-3–positive cells was counted in five different fields of view and divided by the number of DAPI-stained cells (blue) to yield the ratio
of cleaved caspase-3 positive cells; the results are summarized in the accompanying bar graph (n 3). D, effect of RNF183 knockdown on cell viability under
hypertonic conditions. Cells transfected with the indicated siRNAs were treated with isotonic or 200 mM NaCl–supplemented medium for 12 h and analyzed
using a crystal violet assay (n 3). Data were analyzed using a t test (A and D) or one-way ANOVA, followed by post hoc tests using t tests with Bonferroni
correction (B and C). Values represent mean S.D. (error bars). *, p 0.05; **, p 0.01; ***, p 0.001 (versus NC).
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cells. Their effects on adaptation to hypertonicity appear to be
similar to that of RNF183 in the present study. Therefore,
RNF183 expression is induced by hypertonic stress and plays an
important role in the kidney’s osmoprotective function under
hypertonic conditions. However, we could not clarify the sub-
strate of RNF183 under hypertonic conditions. To date, three
previous studies have demonstrated the different functions of
RNF183 in cancers and the colon as follows. (i) In tumors,
RNF183 interacts with fetal and adult testis–expressed 1
(FATE1), which is a cancer/testis antigen, and negatively regu-
lates the apoptotic effector Bcl-2–interacting killer (BIK), a
component of FATE1 complex, leading to increased tumor cell
viability (45). (ii) In the colon, RNF183 degrades IB, thereby
inducing NF-B activation, which might contribute the patho-
genesis of IBD (19). (iii) In the colorectal cancers, RNF183
induces the activation of NF-B and expression of its down-
stream gene, IL8, resulting in increased proliferation and
metastasis of colorectal cancer cells (20). However, FATE1
expression is restricted to cancer or testis and is absent in the
other tissues, such as the kidney (45). Moreover, NF-B activa-
tion by hypertonicity is transient and starts decreasing after 3 h
of hypertonic stimulation in cortical collecting duct cells due to
the restoration of IB protein levels (46, 47). Consistent with
this, the mRNA level of Tnfa, an NF-B downstream gene,
peaked after 3 h of hypertonic stimulation and decreased after
6 h at the time of RNF183 protein level elevation (Fig. S3).
Hence, these results suggest that RNF183 ubiquitylates other
substrates under hypertonic conditions as there is a contradic-
tion on whether the NFAT5-RNF183 axis regulates BIK and
IB expression.
RNF183 expression in response to hypertonicity is mediated
by NFAT5, which is essential for long-term adaptation to
hypertonic conditions (48). Short-term adaptation involves
rapid influx of electrolytes and amino acids through various
transporters, such as Na
-K
-Cl cotransporters, Na
/H

exchangers, Cl/HCO3 exchangers (49), and sodium-coupled
neutral amino acid transporter 2 (50). Long-term adaptation
involves delayed replacement of ionic osmolytes with un-
charged small organic osmolytes via expression of various
enzyme and transporters, such as AKR1B1 (5, 6), BGT1 (4, 6),
and SMIT (3, 6), mediated by NFAT5. However, in long-term
adaptation, themechanismbywhich the dispensable transport-
ers of ionic osmolytes are down-regulated remains unclear.
Here, the punctate signals of RNF183 were predominantly
localized to endosomes and lysosomes (Fig. 1D). Early or late
endosome-localized ubiquitin ligases can sort internalized
cell-surface receptors from the recycling pathway to lysosomal
degradation through ubiquitination (51–53). Therefore, we
speculated that RNF183 plays a role in sorting internalized dis-
pensable transporters to lysosomes for long-term adaptation to
hypertonic conditions.
In summary, NFAT5 directly binds to the conserved DNA
binding site in the Rnf183 enhancer region and leads to Rnf183
transcriptional activation, thereby inducing its high expression
in the renal medulla. Among the transmembrane RNF family
members, Rnf183 is specifically up-regulated by hypertonic
stress and protects the cells from hypertonicity-induced apo-
ptosis.However, our study did not include identification of sub-
strate for RNF183 and validation by animal experiments under
hypertonic conditions. Further study is warranted to elucidate
the localization and function of RNF183 in the kidney.
Experimental procedures
Plasmids
A full-length mouse RNF183 construct with a stop codon
was transferred from pENTR/D-TOPO (catalog no. 45-0218,
Invitrogen) (54) into the Vivid Colors pcDNA6.2/N-EmGFP-
DEST vector (catalog no. 35-1017, Invitrogen) containing
a N-terminal emerald GFP and into pcDNA6.2-DEST (catalog
no. 35-1264, Invitrogen) using Gateway LR Clonase II enzyme
mix (catalog no. 12538-120, Invitrogen). The 3	FLAG-
RNF183 construct synthesized using GeneArt Strings DNA
fragments (Invitrogen) was cloned into the pENTR/D-TOPO
(Invitrogen). The entry clone product was recombined into the
pcDNA6.2-DEST vector using LR Clonase II enzyme mix. The
deletion mutant mouse RNF183 (amino acids 61–158) with a
stop codon was amplified by PCR using the following primer
sets and was subcloned into pENTR/D-TOPO: 5-CACCATG-
CAGCCCACCGT-3 (forward) and 5-TCAGAAGTGAGG-
GTTGCGGACACA-3 (reverse). Subsequently, usingGateway
LR Clonase II enzyme mix, the sequence was transferred into
the pDest-565 vector (catalog no. 11520, Addgene), containing
a GSH S-transferase (GST) at the N terminus of insert
sequences and into the pDest-566 vector (catalog no. 11517,
Addgene) containing a maltose-binding protein (MBP) at the
Figure 9. Rescue of RNF183 knockdown attenuates hypertonicity-in-
duced apoptosis. A, resistance of 3	FLAG-RNF183 to RNF183 siRNA. Mouse
IMCD-3 cells were transfectedwith RNF183 siRNA or NC siRNA. After 12 h, the
cells were electroporated with empty or 3	FLAG-RNF183-pcDNA vectors
and were analyzed by Western blotting 48 h after electroporation. B and C,
effect of rescue of RNF183 knockdown on hypertonicity-induced apoptosis
(B) and cell viability (C). Cells transfectedwith RNF183 siRNAorNC siRNAwere
electroporated with empty or 3	FLAG-RNF183-pcDNA vectors. After 48 h of
electroporation, cells were treated with 200 mM NaCl–supplemented
medium for 4 (B) and 12 h (C) and then analyzed using Western blotting (B)
and a crystal violet assay (C) (n  3), respectively. The accompanying bar
graph summarizes the quantification of the relative amounts of cleaved
caspase-3 (n 3). Data were analyzed by one-way ANOVA, followed by post
hoc tests using t tests with Bonferroni correction. Values represent mean 
S.D. (error bars). *, p 0.05.
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N terminus of the insert sequences. pFLAG-NFAT5, the
expression vector of NFAT5, was gifted to us by Dr. B. C. Ko
(23) and Dr. Takashi Ito (9). The pFLAG-DN-NFAT5 was a
generous gift from Dr. Takashi Ito (9).
Rnf183 promoter fragments were amplified from C57BL/6
murine genomic DNA by PCR using the following primer sets:
3,525 bp (3,465 to
60 region; numbers indicate the nucleo-
tide position relative to the transcription start site), 5-GGT-
ACCTTTCCCAGAAAGCCCATCCC-3 (forward) and 5-
TTTCTCGAGTGTGAGTCACCCCTGCTTTC-3 (reverse);
2,012 bp (1,952 to
60 region), 5-CTGGTACCTCAAGAG-
CCATTGAAAGAACACT-3 (forward) and 5-TTTCTCGA-
GTGTGAGTCACCCCTGCTTTC-3 (reverse). Subsequently,
the purified products were subcloned into the pGL4.10[luc2]
vector (catalog no. 9PIE665, Promega) between KpnI and XhoI
sites, respectively. The resulting vectors were named pGL4–3.5
kbp-Luc and pGL4–2.0 kbp-Luc, respectively. Mutagenesis
of the conserved NFAT5 DNA–binding site (3,358 GTACT-
GCTTAGGCCAGGTACTTTTCCAGCTGGCTGGCCTGC;
NFAT5DNA–binding site is underlined) was performed using
the QuikChange Lightning site-directed mutagenesis kit (cata-
log no. 210518, Agilent Technologies) and the following series
of oligonucleotides (sequence represents antisense strand, with
mutagenized bases represented in lowercase type): mutant,
3,358 GTACTGCTTAGGCCAGGTcCTTaTCaAGCTG-
GCTGGCCTGC.
Antibodies
For obtaining the recombinant deletion mutant, plasmids
containing RNF183 (amino acids 61–158) fused to GST
(pDEST-565) or MBP (pDEST-566) were transformed into the
Escherichia coli strain BL21 (DE3) (catalog no. 69450-3, Milli-
pore, Tokyo, Japan); protein expression was induced by isopro-
pyl -D-1-thiogalactopyranoside (catalog no. R0392, Thermo
Fisher Scientific). Rabbit antiserumwas raised against theGST-
tagged protein, and affinity purification was performed using a
HiTrapNHS-activatedHP column (catalog no. 17-0716-01, GE
Healthcare) coupled with MBP-tagged protein.
Animals
Four-week-old C57BL/6 mice were used in this study. All
animal experiments were performed in accordance with the
National Institutes of Health guidelines for the care and use of
laboratory animals and were approved by the Committee of
Animal Experimentation, Hiroshima University. The mice
were maintained in a room at 23 °C and a constant day–night
cycle and were provided food and water ad libitum.
Cell culture, treatments, and transfection
HEK293, HeLa, mIMCD-3, NRK-49F, and NRK-52E cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; catalog no. 12800-017, Gibco) or DMEM/nutrient
mixture F-12 (DMEM/F-12, catalog no. 12500-062,Gibco) sup-
plemented with 10% (v/v) heat-inactivated fetal bovine serum
at 37 °C in a 5% CO2 and 95% humidified air atmosphere. To
induce hyperosmotic stress, cells received equal volumes of
DMEM/F-12 (control) or 75 mM NaCl or 150 mM sucrose in
DMEM/F-12 for the indicated time, according to the method
reported by Bell et al. (55). For knockdown experiments,
mIMCD-3 cells were transfected with three types of NFAT5-
targeting Silencer siRNA (catalog no. 4390771 (ID: s21069 and
s203948) and catalog no. 4399665 (ID: s550857), Invitrogen) or
an RNF183-targeting Silencer siRNA (catalog no. 4390771 (ID:
s94062), Invitrogen) or a negative control Silencer siRNA (cat-
alog no. 4390843, Invitrogen) as a control using ScreenFect
siRNA (catalog no. 295-75003, Wako Pure Chemical Indus-
tries, Osaka, Japan) in 6-well plates (12.5 pmol/well). HeLa or
HEK293 cells were transfected with each expression plasmid
using ScreenFect A (catalog no. 297-73204, Wako Pure Chem-
ical Industries). For inhibition of p38/MAPK, mIMCD-3 cells
were preincubatedwith SB203580 at 0–25M (catalog no. 199-
16551,WakoPureChemical Industries) for 1 h and treatedwith
75 mM NaCl–supplemented medium for the indicated time,
according to the method reported by Chen et al. (12).
Analysis of mRNA levels inmurine tissues
Total murine tissue RNA was extracted from C57BL/6 mice
using ISOGEN (catalog no. 311-02501, Nippon Gene, Toyama,
Japan) according to the manufacturer’s protocol. Reverse tran-
scription was performed with ReverTra Ace (catalog no. TRT-
101, ToyoboCo., Ltd., Osaka, Japan). PCRwas performed using
the following primer sets in a total volume of 20 l containing
0.2 M of each primer, 0.2 mM dNTPs, 1 unit of Paq5000 DNA
polymerase, and 10	 PCR buffer (catalog no. 600680, Agilent
Technologies): mouse Rnf183, 5-GACCAGCCCAAGAGCC-
GCTA-3 (forward) and 5-CCCCAAAAGAACTGCTTAGT-
CCA-3 (reverse); mouseMegalin, 5-CTCCTGCAAGTCGG-
TCCATT-3 (forward) and 5-GACCGCCCAGTAGAGC-
TTTT-3 (reverse); mouse Akr1b1, 5-AGAGCATGGTGAA-
AGGAGCC-3 (forward) and 5-TGGCACTCGATCTGGTT-
CAC-3 (reverse). The PCR conditions were as follows: 94 °C
for 2min, 22–26 cycles at 98 °C for 10 s, 60 °C for 30 s, 72 °C for
30 s, and 72 °C for 3 min. The PCR products were resolved by
electrophoresis on a 4.8% acrylamide gel. The density of each
band was quantified using the Adobe Photoshop Elements ver-
sion 2.0 program (Adobe Systems Inc.).
Analysis of mRNA levels in culture cells
Total RNA from mIMCD-3 cells was extracted using
ISOGEN. Reverse transcription was performed with ReverTra
Ace. The reverse-transcribed cDNA was measured by TaqMan-
based real-time PCR assay using theCtmethod. The following
TaqMan primer and probe sets, purchased from Integrated DNA
Technologies (Coralville, IA) were used: mouse Rnf183 (assay ID:
Mm.PT.58.42013627), mouseAkr1b1 (assay ID: 214320988), mouse
Hspa1b (assay ID: Mm.PT.58.31570020.g), mouse Vegfa (assay
ID: Mm.PT.58.31754187), mouse Tnfa (assay ID: Mm.PT.58.
29509614), mouse Rnf130 (assay ID: Mm.PT.58.9219868),
mouse Rnf150 (assay ID: Mm.PT.58.10273312), mouse Rnf149
(assay ID: Mm.PT.58.11306683), mouse Rnf133 (assay ID:
Mm.PT.58.43776563.g), mouse Rnf128 (assay ID: Mm.PT.
56a.8462982), mouse Rnf122 (assay ID: Mm.PT.58.8505793),
mouse Rnf24 (assay ID: Mm.PT.58.9635653), mouse Rnf13
(assay ID: Mm.PT.58.11306683), mouse Rnf167 (assay ID:
Mm.PT.58.32670381), mouse Znf4 (assay ID: Mm.PT.58.
32478833.g), mouse Rnf43 (assay ID: Mm.PT.56a.31556976),
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mouse Znf3 (assay ID: Mm.PT.56a.5645486), mouse Syvn1
(assay ID: Mm.PT.58.14132695), mouse Amfr (assay ID:
Mm.PT.58.9856954), mouse Rnf121 (assay ID: Mm.PT.58.
6378114), mouse Rnf145 (assay ID: Mm.PT.58.10110397),
mouse Rnf139 (assay ID: Mm.PT.58.45812642), mouse Rnf103
(assay ID: Mm.PT.58.9763784), mouse Rnf19A (assay ID:
Mm.PT.58.28600163), mouse Rnf19B (assay ID: Mm.PT.58.
28736280), mouse Rnf5 (assay ID: Mm.PT.58.14209781),
mouseRnf185 (assay ID:Mm.PT.56a.11642500),mouseRnf170
(assay ID: Mm.PT.56a.13272002), mouse Rnf186 (assay ID:
Mm.PT.56a.29338718.g), mouse Rnf152 (assay ID: Mm.PT.58.
29277956.g), mouse Rnf182 (assay ID: Mm.PT.58.30902864.g),
mouseTrim59 (assay ID:Mm.PT.58.30417218),mouseTrim13
(assay ID: Mm.PT.56a.9751937), mouse Bfar (assay ID:
Mm.PT.56a.28494992), mouse Rnf180 (assay ID: Mm.PT.58.
45835696),mouseRnft1 (assay ID:Mm.PT.58.6836835),mouse
Rnf26 (assay ID: Mm.PT.58.5764306.g), mouse Cgrnf1 (assay
ID: Mm.PT.58.5664724), mouse Mul1 (assay ID: Mm.PT.58.
11670267), and mouse Rnf217 (assay ID: Mm.PT.56a.
33323466). Mouse -actin TaqMan primer and probe set was
as follows: 5-GCGGTTCCGATGCCCT-3 (forward), 5-
CATGGATGCCACAGGATTCC-3 (reverse), and 5-AGG-
CTCTTTTCCAGCCTTCCTTCTTGG-3 (probe).
Western blotting
Tissue or cell lysates were prepared in 1	 Laemmli sample
buffer. Equivalent protein samples were loaded onto SDS-poly-
acrylamide gels. Gels were transferred to Immobilon-P polyvi-
nylidene difluoride membranes (catalog no. IPVH00010, Milli-
pore) and blocked in 5% nonfat dry milk at room temperature
for 1 h. Themembrane was incubated with primary antibody at
4 °C overnight and with secondary antibody at room tempera-
ture for 1 h. The following primary antibodies were used: anti-
-actin (catalog no. sc47778, Santa Cruz Biotechnology, Inc.),
anti-aldose reductase (catalog no. sc271007, Santa Cruz Bio-
technology), anti-cleaved caspase-3 (catalog no. 9661, Cell Sig-
naling Technology), anti-GFP (catalog no. 598,Medical Biolog-
ical Laboratories, Nagoya, Japan), anti-megalin (catalog no.
101-M144, ReliaTech GmbH, Germany), anti-NFAT5 (catalog
no. ab3446, Abcam, UK), and anti-RNF183. The secondary
antibodies used were as follows: horseradish peroxidase–
conjugated goat anti-mouse IgG antibody (catalog no. 1031-05
Southern Biotech) and horseradish peroxidase–conjugated
goat anti-rabbit antibodies (catalog no. 4050-05 Southern Bio-
tech). Images were obtained using a WSE-6100 LuminoGraph
(ATTO Corp., Tokyo, Japan).
Immunofluorescence
Cells were fixed in 4% paraformaldehyde at room tempera-
ture for 10 min and then permeabilized in methanol at20 °C
for 10min. Cells were blockedwith 5% anti-goat serum at room
temperature for 30min and incubatedwith primary antibody at
4 °C overnight and then with Alexa Fluor–conjugated second-
ary antibodies at room temperature for 30 min. The following
primary antibodies were used: anti-GFP (catalog no. 598, Med-
ical Biological Laboratories), anti-NFAT5 (catalog no. ab3446,
Abcam), anti-cleaved caspase-3 (catalog no. 9661, Cell Signal-
ing Technology), anti-calnexin (catalog no. 2679, Cell Signaling
Technology), anti-COX IV (catalog no. 4850, Cell Signaling
Technology), anti-EEA1(catalogno.3288,CellSignalingTechnol-
ogy), anti-GM130 (catalog no. 12480, Cell Signaling Technology),
anti-transferrin receptor (catalog no. 13-6800, Invitrogen), and
anti-Lamp1 (catalog no. 9091, Cell Signaling Technology). The
secondary antibodies usedwere as follows: goat anti-mouse Alexa
Fluor 555 (catalogno.A-21422, Invitrogen), goat anti-rabbitAlexa
Fluor 568 (catalog no. A-11036, Invitrogen), goat anti-mouse
Alexa Fluor 488 (catalog no. A-11001, Invitrogen), and goat anti-
rabbitAlexa Fluor 488 (catalog no.A-11070, Invitrogen). ProLong
Diamond Antifade Mountant with DAPI (catalog no. P36962,
Invitrogen) was used to mount slips on glass slides. Fluorescence
imageswere acquiredusing anOlympusFluoViewFV1000 confo-
cal microscope (Olympus, Tokyo, Japan). Apoptotic cells were
counted in five different fields of view, and the ratio of the number
of cleaved caspase 3–positive cells to that of DAPI-stained cells
was calculated.
Luciferase assay
Mouse IMCD-3 cells were transiently transfectedwith 0.2g
of pGL4.10[luc2] carrying both the firefly luciferase gene and
the referenced constructs and 0.02 g of pGL4.74[hRluc/TK]
carrying the Renilla luciferase gene under the control of the
herpes simplex virus thymidine kinase enhancer and promoter
(catalog no. 9PIE692, Promega) in the presence of NFAT5
siRNA 1, NFAT5 siRNA 2 (catalog no. 4390771, Invitrogen),
NFAT5 siRNA 3 (catalog no. 4399665, Invitrogen), NC siRNA
(catalog no. 4390843, Invitrogen), or empty, pFLAG-DN-
NFAT5, or pFLAG-NFAT5 vectors; the transfection was per-
formed using ScreenFect A (catalog no. 297-73204,Wako Pure
Chemical Industries) under conditions recommended by the
manufacturer. For rescue of NFAT5 knockdown, cells pre-
transfected with siRNA (NFAT5 siRNA 3 or NC) using Screen-
Fect siRNA (catalog no. 295-75003, Wako Pure Chemical
Industries) were cotransfected with 3.5 kbp-Luc and either
empty or pFLAG-NFAT5 vectors after 12 h of knockdown.
Twenty-four hours after transfection, cells were treatedwith 75
mM NaCl or 150 mM sucrose in DMEM/F-12 for 24 h. Cells
were washed twice with PBS and subsequently lysed with Pas-
sive Lysis Buffer (catalog no. 194A, Promega). Luciferase activ-
ities were measured with the Dual-Luciferase Reporter Assay
System (catalog no. 1960, Promega) and a GloMax Multi

Detection System (Promega), according to the manufacturer’s
protocol. Relative activity was defined as the ratio between the
activities of firefly luciferase and Renilla luciferase. The vector
pGL4.10[luc2] without the promoter (pGL4-Luc) was used as a
negative control.
ChIP assay
Two 10-cm plates of 80% confluent mIMCD-3 cells were
cultured for 24 h and treated with 75 mM NaCl for 4 h prior to
cross-linking. Cellswere treatedwith 1% (v/v) formaldehyde for
15 min at 37 °C, followed by an additional 5 min in 150 mM
glycine. Subsequently, cells were washed with cold PBS and
lysed in nuclear lysis buffer (50 mM Tris-HCl (pH 8.0), 10 mM
EDTA, 1% SDS, and protease inhibitor mixture) for 10 min on
ice. Nuclear lysates were sonicated to a final average fragment
length of 1,000 bp using a Bioruptor II (BM Equipment, Tokyo,
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Japan). Sonicated chromatin was cleared by centrifugation at
13,000 rpm for 10 min and then diluted 10-fold with dilution
buffer (16.7 mM Tris-HCl (pH 8.0), 1.2 mM EDTA, 0.01% SDS,
1.1% Triton X-100, 167 mM NaCl, and protease inhibitor mix-
ture). The soluble chromatinwas incubatedwith 2g of normal
IgG rabbit (catalog no. 2729, Cell Signaling Technology) or
anti-NFAT5 antibody (catalog no. ab3446, Abcam) on a rotat-
ing platform at 4 °C overnight, followed by incubation with 20
l of Magna ChIP Protein A 
 G magnetic beads (catalog no.
16-663,Millipore) for 1 h. Subsequently, the beadswerewashed
with the following four buffers: low-salt buffer (20mMTris-HCl
(pH 8.0), 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 150 mM
NaCl), high-salt buffer (same as low-salt buffer with 500 mM
NaCl), LiCl buffer (10mMTris-HCl (pH 8.0), 1 mM EDTA, 0.25
M LiCl, 1% Nonidet P-40, 1% sodium deoxycholate), and TE
buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA). Precipitated
complexes were eluted twice from the beads in fresh elution
buffer (1% SDS, 0.1 M NaHCO3) for 30 min each at room tem-
perature and subsequently heated at 65 °C overnight to reverse
formaldehyde-induced cross-linking. TheDNAwas purified by
phenol–chloroform extraction and ethanol precipitation. The
purified DNA was amplified by PCR in a total volume of 20 l
containing a 0.45 M concentration of each primer, 0.4 mM
dNTPs, 1 unit of KODFXDNApolymerase, and 2	PCRbuffer
(catalog no. KFX-101, Toyobo). The following primer set was
used, yielding a 303-bp product: 5-GTTTTACCCTTTTGC-
CTGTTTCCTT-3 (forward) and 5-CAGGCTAAGAAGTC-
CTTGGTAAACA-3 (reverse). The PCR conditions were as
follows: 94 °C for 5min, 33 cycles at 94 °C for 15 s, 60 °C for 30 s,
68 °C for 20 s, and 68 °C for 3 min. The PCR products were
resolved by electrophoresis on a 4.8% acrylamide gel. The den-
sity of each band was quantified using the Adobe Photoshop
Elements version 2.0 program (Adobe Systems Inc.).
Cell viability assay
mIMCD-3 cells were transfected with RNF183 or NC siRNA
in 6-well plates (12.5 pmol/well). After 24 h, the cells were
reseeded in a 24-well plate and cultured in 5% CO2 at 37 °C for
an additional 24 h. Subsequently, cells were treated with iso-
tonic or 200 mM NaCl–supplemented medium in 5% CO2 at
37 °C for 12 h and washed with PBS and then stained with crys-
tal violet. The wells were washed with water and air-dried, and
the dye was eluted with water-containing 0.5% SDS. The absor-
bancewasmeasured at 590nmusing aBio-Rad SmartSpec 3000
spectrophotometer, according to the method reported by
Omura et al. (56).
Electroporation
For RNF183 rescue experiments using electroporation,
mIMCD-3 cells were transfected with RNF183 or NC siRNA in
10-cm dishes (62.5 pmol/dish). After 12 h, the cells were
trypsinized and resuspended in DMEM/F-12. They were then
pelleted at 1,000 rpm for 5 min and resuspended in Opti-MEM
at a working concentration of 1.0 	 107 cells/ml. One hun-
dredmicroliters of cell suspensionwas added to 10g of empty
or 3	FLAG-RNF183-pcDNA vectors in electroporation
cuvettes (catalog no. SE-202, BEX Co., Ltd., Tokyo, Japan) and
then transfected by one direct-current 150-V electrical pulse
and five direct-current 20-V electrical pulses at intervals of 50
ms using an electroporator (CUY 21 Vitro-EX, BEX Co.). After
48 h, cells were treated with 200 mM NaCl in DMEM/F-12 for
the indicated time and analyzed using Western blotting or a
crystal violet assay.
Statistical analysis
Results are expressed as the mean  S.D. Statistical evalua-
tion was performed using JMP statistical software (version Pro
12). Comparisons between two groups were analyzed using the
two-tailed t test. For multiple-group comparisons, one-way
analysis of variance (ANOVA), followed by two-tailed Student’s
t test with Bonferroni correction were applied. Significant p
values are as follows: *, p 0.05; **, p 0.01; and ***, p 0.001.
Nonsignificant p values are shown as N.S. (p 0.05).
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